NeueHealth (NYSE:NEUE) Announces Earnings Results, Misses Expectations By $5.12 EPS

NeueHealth (NYSE:NEUE) released its quarterly earnings results on Thursday. The company reported ($7.41) EPS for the quarter, missing analysts’ consensus estimates of ($2.29) by ($5.12), Zacks reports. The business had revenue of $232.64 million for the quarter, compared to the consensus estimate of $261.80 million. NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%.

NeueHealth Stock Performance

NYSE:NEUE opened at $5.49 on Friday. The stock’s fifty day moving average price is $7.03 and its two-hundred day moving average price is $6.00. NeueHealth has a 52-week low of $3.79 and a 52-week high of $7.66. The company has a market cap of $45.45 million, a price-to-earnings ratio of -0.11 and a beta of 0.56.

Insiders Place Their Bets

In other NeueHealth news, CEO George Lawrence Mikan III sold 31,798 shares of the company’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $233,079.34. Following the transaction, the chief executive officer now owns 146,539 shares of the company’s stock, valued at approximately $1,074,130.87. This represents a 17.83 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jay Matushak sold 4,970 shares of the stock in a transaction on Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $36,430.10. Following the completion of the transaction, the chief financial officer now directly owns 17,747 shares in the company, valued at approximately $130,085.51. This trade represents a 21.88 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 110,033 shares of company stock valued at $774,560. 64.30% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Separately, Royal Bank of Canada decreased their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.